Cargando…

Two Cases of Lassa Fever Successfully Treated with Ribavirin and Adjunct Dexamethasone for Concomitant Infections

Lassa fever is a viral hemorrhagic fever treated with supportive care and the broad-spectrum antiviral drug ribavirin. The pathophysiology, especially the role of hyperinflammation, of this disease is unknown. We report successful remission of complicated Lassa fever in 2 patients in Nigeria who rec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okogbenin, Sylvanus, Erameh, Cyril, Okoeguale, Joseph, Edeawe, Osahogie, Ekuaze, Esele, Iraoyah, Kelly, Agho, John, Groger, Mirjam, Kreuels, Benno, Oestereich, Lisa, Babatunde, Femi O., Akhideno, Peter, Günther, Stephan, Ramharter, Michael, Omansen, Till
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2022
Materias:	Dispatch
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9514364/ https://www.ncbi.nlm.nih.gov/pubmed/36148915 http://dx.doi.org/10.3201/eid2810.220625

Ejemplares similares

Prospective observational study on the pharmacokinetic properties of the Irrua ribavirin regimen used in routine clinical practice in patients with Lassa fever in Nigeria
por: Erameh, Cyril, et al.
Publicado: (2020)

Pharmacokinetics of Ribavirin in the Treatment of Lassa Fever: An Observational Clinical Study at the Irrua Specialist Teaching Hospital, Edo State, Nigeria
por: Groger, Mirjam, et al.
Publicado: (2022)

Determining Ribavirin’s mechanism of action against Lassa virus infection
por: Carrillo-Bustamante, Paola, et al.
Publicado: (2017)

Psychiatric manifestations and associated risk factors among hospitalised patients with COVID-19 in Edo State, Nigeria: a cross-sectional study
por: Okogbenin, Esther Osemudiamen, et al.
Publicado: (2022)

Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study
por: Kayem, Nzelle Delphine, et al.
Publicado: (2023)

Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study
por: Kayem, Nzelle Delphine, et al.
Publicado: (2023)

Atypical presentation of mpox in Irrua environs: a case report
por: Oiwoh, S. O., et al.
Publicado: (2023)

Ribavirin for Lassa Fever Postexposure Prophylaxis
por: Hadi, Christiane M., et al.
Publicado: (2010)

One-Year Retrospective Review of Psychiatric Consultations in Lassa Fever, Southern Nigeria
por: Okogbenin, Esther O., et al.
Publicado: (2020)

Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
por: Oestereich, Lisa, et al.
Publicado: (2016)

Time to reconsider the role of ribavirin in Lassa fever
por: Salam, Alex Paddy, et al.
Publicado: (2021)

A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever
por: Olayinka, Adebola Tolulope, et al.
Publicado: (2022)

Retrospective Cohort Study of Lassa Fever in Pregnancy, Southern Nigeria
por: Okogbenin, Sylvanus, et al.
Publicado: (2019)

Acute Lassa Virus Encephalitis with Lassa Virus in the Cerebrospinal Fluid but Absent in the Blood: A Case Report with a Positive Outcome
por: Okokhere, Peter O., et al.
Publicado: (2018)

The unusual finding of peripheral lymphadenopathy among confirmed Lassa fever patients in Nigeria
por: Owhin, Sampson O, et al.
Publicado: (2023)

Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin
por: Lingas, Guillaume, et al.
Publicado: (2021)

Phylogeography of Lassa Virus in Nigeria
por: Ehichioya, Deborah U., et al.
Publicado: (2019)

Traveling into the Abyss: Risk Perception of German Travelers at the Onset of the COVID-19 Pandemic
por: Shamsrizi, Parichehr, et al.
Publicado: (2020)

Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies
por: Cheng, Hung-Yuan, et al.
Publicado: (2022)

Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak
por: Boisen, Matthew L., et al.
Publicado: (2020)

Increase in Lassa Fever Cases in Nigeria, January–March 2018
por: Ilori, Elsie A., et al.
Publicado: (2019)

Ribavirin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing
por: Salam, Alex P., et al.
Publicado: (2022)

Postexposure prophylaxis for Lassa fever: Experience from a recent outbreak in Nigeria
por: Isa, Samson E., et al.
Publicado: (2016)

Caseload and Case Fatality of Lassa Fever in Nigeria, 2001–2018: A Specialist Center's Experience and Its Implications
por: Akpede, George O., et al.
Publicado: (2019)

Real-life effectiveness of anti-malarial treatment regimens: what are we aiming for?
por: Mbassi, Dorothea Ekoka, et al.
Publicado: (2023)

Corrigendum: Caseload and Case Fatality of Lassa Fever in Nigeria, 2001–2018: A Specialist Center's Experience and Its Implications
por: Akpede, George O., et al.
Publicado: (2019)

Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
por: Oestereich, Lisa, et al.
Publicado: (2023)

Prevalence of Lassa Virus Disease (LVD) in Nigerian children with fever or fever and convulsions in an endemic area
por: Akhuemokhan, Odigie C., et al.
Publicado: (2017)

Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018
por: Ilori, Elsie A., et al.
Publicado: (2019)

Lassa fever in Benin: description of the 2014 and 2016 epidemics and genetic characterization of a new Lassa virus
por: Yadouleton, Anges, et al.
Publicado: (2020)

High crossreactivity of human T cell responses between Lassa virus lineages
por: Sullivan, Brian M., et al.
Publicado: (2020)

Genomic analysis of Lassa virus from the 2018 surge in Nigeria
por: Siddle, Katherine J., et al.
Publicado: (2018)

Lassa Fever 2016 Outbreak in Plateau State, Nigeria—The Changing Epidemiology and Clinical Presentation
por: Shehu, Nathan Y., et al.
Publicado: (2018)

Berberine for Adjunct/Alternative Treatment of Dyslipidemia: A Literature Review
por: Evbayekha, Endurance O, et al.
Publicado: (2023)

Predicting the evolution of the Lassa virus endemic area and population at risk over the next decades
por: Klitting, Raphaëlle, et al.
Publicado: (2022)

PROSPECTS OF LASSA FEVER CANDIDATE VACCINES
por: Isaac, Ademusire Babatunde, et al.
Publicado: (2022)

Antibodies from Sierra Leonean and Nigerian Lassa fever survivors cross-react with recombinant proteins representing Lassa viruses of divergent lineages
por: Heinrich, Megan L., et al.
Publicado: (2020)

Development and evaluation of antibody-capture immunoassays for detection of Lassa virus nucleoprotein-specific immunoglobulin M and G
por: Gabriel, Martin, et al.
Publicado: (2018)

Chimeric Mice with Competent Hematopoietic Immunity Reproduce Key Features of Severe Lassa Fever
por: Oestereich, Lisa, et al.
Publicado: (2016)

Reply to Lin et al
por: Groger, Mirjam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rusfnme1qssn3q0knh1fbafnou